Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
5.54
-0.11 (-1.95%)
At close: Jul 25, 2025, 4:00 PM
5.51
-0.03 (-0.54%)
After-hours: Jul 25, 2025, 6:47 PM EDT

Sensus Healthcare Stock Forecast

Stock Price Forecast

The 3 analysts that cover Sensus Healthcare stock have a consensus rating of "Strong Buy" and an average price target of $11.67, which forecasts a 110.65% increase in the stock price over the next year. The lowest target is $10 and the highest is $13.

Price Target: $11.67 (+110.65%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$10$11.67$12$13
Change+80.51%+110.65%+116.61%+134.66%
* Price targets were last updated on May 19, 2025.

Analyst Ratings

The average analyst rating for Sensus Healthcare stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy233333
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total233333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Strong Buy
Maintains
$14$10
Strong BuyMaintains$14$10+80.51%May 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong BuyReiterates$12+116.61%Apr 4, 2025
Lake Street
Lake Street
Strong Buy
Maintains
$18$13
Strong BuyMaintains$18$13+134.66%Mar 11, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$11$12
Strong BuyMaintains$11$12+116.61%Feb 10, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$10$11
Strong BuyMaintains$10$11+98.56%Nov 18, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
43.62M
from 41.81M
Increased by 4.33%
Revenue Next Year
55.28M
from 43.62M
Increased by 26.74%
EPS This Year
0.11
from 0.41
Decreased by -72.47%
EPS Next Year
0.49
from 0.11
Increased by 332.73%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
9.58M27.04M44.53M24.41M41.81M43.62M55.28M65.10M
Revenue Growth
-64.87%182.36%64.68%-45.20%71.30%4.33%26.74%17.75%
EPS
-0.420.251.460.030.410.110.490.59
EPS Growth
--484.00%-97.96%1,266.06%-72.47%332.73%20.80%
Forward PE
-----49.3811.419.45
No. Analysts
-----774
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High53.4M73.8M75.0M
Avg43.6M55.3M65.1M
Low36.3M43.5M55.1M

Revenue Growth

Revenue Growth20252026202720282029
High
27.8%
69.2%
35.6%
Avg
4.3%
26.7%
17.8%
Low
-13.3%
-0.2%
-0.3%

EPS Forecast

EPS20252026202720282029
High0.331.040.98
Avg0.110.490.59
Low-0.040.160.22

EPS Growth

EPS Growth20252026202720282029
High
-20.1%
826.5%
101.1%
Avg
-72.5%
332.7%
20.8%
Low-
39.8%
-55.6%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.